SEARCH

SEARCH BY CITATION

References

  • 1
    Jemal A,Siegel R,Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008; 58: 71-96.
  • 2
    Espey DK,Wu XC,Swan J, et al. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer. 2007; 110: 2119-2152.
  • 3
    Irby K,Anderson WF,Henson DE,Devesa SS. Emerging and widening colorectal carcinoma disparities between blacks and whites in the United States (1975–2002). Cancer Epidemiol Biomarkers Prev. 2006; 15: 792-797.
  • 4
    Polite BN,Dignam JJ,Olopade OI. Colorectal cancer model of health disparities: understanding mortality differences in minority populations. J Clin Oncol. 2006; 24: 2179-2187.
  • 5
    McCracken M,Olsen M,Chen MSJr, et al. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin. 2007; 57: 190-205.
  • 6
    Le H,Ziogas A,Lipkin SM,Zell JA. Effects of socioeconomic status and treatment disparities in colorectal cancer survival. Cancer Epidemiol Biomarkers Prev. 2008; 17: 1950-1962.
  • 7
    Seiffert JE,Price WT,Gordon B. The California tumor registry: a state-of-the-art model for a regionalized, automated, population-based registry. Top Health Rec Manage. 1990; 11: 59-73.
  • 8
    Parikh-Patel A,Bates JH,Campleman S. Colorectal cancer stage at diagnosis by socioeconomic and urban/rural status in California, 1988–2000. Cancer. 2006; 107: 1189-1195.
  • 9
    Cancer Reporting in California.Standards for Automated Reporting. California Cancer Reporting System Standards. Vol II. Sacramento, CA: California Department of Health Services, Cancer Surveillance Section; 1997.
  • 10
    Cancer Reporting in California.Data Standards for Regional Registries and California Cancer Registry. California Cancer Reporting System Standards. Vol III. Sacramento, CA: California Department of Health Services, Cancer Surveillance Section; 1997.
  • 11
    Cancer Reporting in California.Reporting Procedures for Physicians. California Cancer Reporting System Standards. Vol IV. Sacramento, CA: California Department of Health Services, Cancer Surveillance Section; 1998.
  • 12
    California Cancer Registry. How complete are California Cancer Registry data? 2007. Available at: http://www.ccrcal.org/questions.html Accessed on November 15, 2008.
  • 13
    Cancer Reporting in California. Abstracting and Coding Procedures for Hospitals. California Cancer Reporting System Standards. Vol I. Sacramento, CA: California Department of Health Services, Cancer Surveillance Section; 1997.
  • 14
    Fritz A,Percy C,Jack A, et al. International Classification of Diseases for Oncology. 3rd ed. Geneva, Switzerland: World Health Organization; 2000.
  • 15
    Yost K,Perkins C,Cohen R,Morris C,Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control. 2001; 12: 703-711.
  • 16
    Zell JA,Rhee JM,Ziogas A,Lipkin SM,Anton-Culver H. Race, socioeconomic status, treatment, and survival time among pancreatic cancer cases in California. Cancer Epidemiol Biomarkers Prev. 2007; 16: 546-552.
  • 17
    Zell JA,Cinar P,Mobasher M,Ziogas A,Meyskens FLJr,Anton-Culver H. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment. J Clin Oncol. 2008; 26: 66-75.
  • 18
    Wu X,Chen VW,Martin J, et al. Subsite-specific colorectal cancer incidence rates and stage distributions among Asians and Pacific Islanders in the United States, 1995 to 1999. Cancer Epidemiol Biomarkers Prev. 2004; 13: 1215-1222.
  • 19
    Wong ST,Gildengorin G,Nguyen T,Mock J. Disparities in colorectal cancer screening rates among Asian Americans and non-Latino whites. Cancer. 2005; 104: 2940-2947.
  • 20
    Fearon ER,Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 1990; 61: 759-767.
  • 21
    Flood DM,Weiss NS,Cook LS,Emerson JC,Schwartz SM,Potter JD. Colorectal cancer incidence in Asian migrants to the United States and their descendants. Cancer Causes Control. 2000; 11: 403-411.
  • 22
    Meyerhardt JA,Niedzwiecki D,Hollis D, et al. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer. JAMA. 2007; 298: 754-764.
  • 23
    Bufill JA. Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. Ann Intern Med. 1990; 113: 779-788.
  • 24
    Wiencke JK,Zheng S,Lafuente A, et al. Aberrant methylation of p16INK4a in anatomic and gender-specific subtypes of sporadic colorectal cancer. Cancer Epidemiol Biomarkers Prev. 1999; 8: 501-506.
  • 25
    Gervaz P,Bouzourene H,Cerottini JP, et al. Dukes B colorectal cancer: distinct genetic categories and clinical outcome based on proximal or distal tumor location. Dis Colon Rectum. 2001; 44: 364-372; discussion372-373.
  • 26
    Lothe RA,Peltomaki P,Meling GI, et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res. 1993; 53: 5849-5852.
  • 27
    Lengauer C,Kinzler KW,Vogelstein B. Genetic instability in colorectal cancers. Nature. 1997; 386: 623-627.
  • 28
    Azzoni C,Bottarelli L,Campanini N, et al. Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. Int J Colorectal Dis. 2007; 22: 115-126.
  • 29
    Russo A,Bazan V,Iacopetta B,Kerr D,Soussi T,Gebbia N. The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment. J Clin Oncol. 2005; 23: 7518-7528.
  • 30
    Bunz F,Hwang PM,Torrance C, et al. Disruption of p53 in human cancer cells alters the responses to therapeutic agents. J Clin Invest. 1999; 104: 263-269.
  • 31
    Hoskins JM,Marcuello E,Altes A, et al. Irinotecan pharmacogenetics: influence of pharmacodynamic genes. Clin Cancer Res. 2008; 14: 1788-1796.
  • 32
    Huang MY,Fang WY,Lee SC,Cheng TL,Wang JY,Lin SR. ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: a preliminary study. BMC Cancer. 2008; 8: 50.
  • 33
    Liu W,Innocenti F,Chen P,Das S,Cook EHJr,Ratain MJ. Interethnic difference in the allelic distribution of human epidermal growth factor receptor intron 1 polymorphism. Clin Cancer Res. 2003; 9: 1009-1012.
  • 34
    American FactFinder. US Census Bureau data for California. Available at: http://www.census.gov 2000 Accessed on June 1, 2008.
  • 35
    Rolnick S,Hensley Alford S,Kucera GP, et al. Racial and age differences in colon examination surveillance following a diagnosis of colorectal cancer. J Natl Cancer Inst Monogr. 2005;( 35): 96-101.
  • 36
    Cooper GS,Yuan Z,Chak A,Rimm AA. Geographic and patient variation among Medicare beneficiaries in the use of follow-up testing after surgery for nonmetastatic colorectal carcinoma. Cancer. 1999; 85: 2124-2131.
  • 37
    Meyerhardt JA,Giovannucci EL,Holmes MD, et al. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol. 2006; 24: 3527-3534.
  • 38
    Meyerhardt JA,Heseltine D,Niedzwiecki D, et al. Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol. 2006; 24: 3535-3541.